Global Market for Anti-obesity Drugs
Report Scope:
The report’s scope includes an overview of the global market for anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.
The report analyzes anti-obesity drugs by drug types, assesses distribution channels, and provides an overview regarding product pipeline of major players in market. Leading market players’ profiles, marketed products, pipeline products, and recent market activities are provided. The report details market for anti-obesity drugs based on drug type, distribution channel, and region. Based on drug type, the market is segmented into prescription drugs, and over-the-counter (OTC) drugs. The market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies on the basis of distribution channel. Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).
Report Includes:An overview of the current and future global markets for anti-obesity drugs Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028 Estimate of the actual market size and revenue forecast for the global anti-obesity drugs market, and corresponding market share analysis based on drug type, distribution channel, and region Overview of ESG outlook with emphasis on sustainability trends and factors on anti-obesity drugs market Identification of the major vendors in the global market for anti-obesity drugs, along with an analysis of the structure of this industry, including company market shares, M&A deals and venture fundings Profiles of the leading global players
The report’s scope includes an overview of the global market for anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.
The report analyzes anti-obesity drugs by drug types, assesses distribution channels, and provides an overview regarding product pipeline of major players in market. Leading market players’ profiles, marketed products, pipeline products, and recent market activities are provided. The report details market for anti-obesity drugs based on drug type, distribution channel, and region. Based on drug type, the market is segmented into prescription drugs, and over-the-counter (OTC) drugs. The market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies on the basis of distribution channel. Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).
Report Includes:
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Research Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Market Outlook
Market Summary
CHAPTER 3 MARKET OVERVIEW
Definitions of Adult Obesity and Overweight
Overweight- and Obesity-Related Diseases
Rising Prevalence of Obesity
Impact of Obesity on Global Economy
Increasing Awareness Regarding Obesity
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
CHAPTER 4 GLOBAL MARKET FOR ANTI-OBESITY DRUGS BY TYPE
Prescription Drugs
Over-the-Counter Anti-obesity Drugs
CHAPTER 5 GLOBAL MARKET FOR ANTI-OBESITY DRUGS BY DISTRIBUTION CHANNEL
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
CHAPTER 6 GLOBAL MARKET FOR ANTI-OBESITY DRUGS BY REGION
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 7 ESG DEVELOPMENTS
Introduction to ESG
Importance of ESG in Anti-obesity Drugs Industry
ESG Pillars in the Anti-obesity Drug Industry
Environmental Metrics
Social Metrics
Governance Metrics
ESG Ratings and Metrics: Understanding the Data
ESG Practices in the Anti-obesity Drug Industry
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
CHAPTER 8 COMPETITIVE LANDSCAPE
Overview
Pipeline Analysis
Patents on Obesity Management, 2020-2023
CHAPTER 9 COMPANY PROFILES
ALTIMMUNE INC.
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CURRAX PHARMACEUTICALS LLC
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
NOVO NORDISK A/S
PFIZER INC.
RHYTHM PHARMACEUTICALS, INC.
VIVUS LLC
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Research Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Market Outlook
Market Summary
CHAPTER 3 MARKET OVERVIEW
Definitions of Adult Obesity and Overweight
Overweight- and Obesity-Related Diseases
Rising Prevalence of Obesity
Impact of Obesity on Global Economy
Increasing Awareness Regarding Obesity
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
CHAPTER 4 GLOBAL MARKET FOR ANTI-OBESITY DRUGS BY TYPE
Prescription Drugs
Over-the-Counter Anti-obesity Drugs
CHAPTER 5 GLOBAL MARKET FOR ANTI-OBESITY DRUGS BY DISTRIBUTION CHANNEL
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
CHAPTER 6 GLOBAL MARKET FOR ANTI-OBESITY DRUGS BY REGION
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 7 ESG DEVELOPMENTS
Introduction to ESG
Importance of ESG in Anti-obesity Drugs Industry
ESG Pillars in the Anti-obesity Drug Industry
Environmental Metrics
Social Metrics
Governance Metrics
ESG Ratings and Metrics: Understanding the Data
ESG Practices in the Anti-obesity Drug Industry
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
CHAPTER 8 COMPETITIVE LANDSCAPE
Overview
Pipeline Analysis
Patents on Obesity Management, 2020-2023
CHAPTER 9 COMPANY PROFILES
ALTIMMUNE INC.
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CURRAX PHARMACEUTICALS LLC
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
NOVO NORDISK A/S
PFIZER INC.
RHYTHM PHARMACEUTICALS, INC.
VIVUS LLC
LIST OF TABLES
Summary Table : Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 1 : Definitions of Adult Obesity and Overweight
Table 2 : Number of People, Aged Over 5 Years, and Percentage of the Population With Overweight or Obesity, 2020-2035
Table 3 : Global Obesity Trends for Children and Adolescents, Aged 5 to 19 Years, by Gender, 2020-2035
Table 4 : Global Obesity Trends for Adults, Aged 20 Years and Above, by Gender, 2020-2035
Table 5 : Global Economic Impact of High BMI (BMI ?25kg/m?), 2020-2035
Table 6 : Global Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 7 : Difference between Prescription Drugs and Over-the-Counter Anti-obesity Drugs
Table 8 : Approved Prescription Drugs to Treat Overweight and Obesity
Table 9 : Global Market for Anti-obesity Prescription Drugs, by Region, Through 2028
Table 10 : Global Market for Over-the-Counter Anti-obesity Drugs, by Region, Through 2028
Table 11 : Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 12 : Global Market for Anti-obesity Drugs Sold through Hospital Pharmacies, by Region, Through 2028
Table 13 : Global Market for Anti-obesity Drugs Sold through Retail Pharmacies, by Region, Through 2028
Table 14 : Global Market for Anti-obesity Drugs Sold through Online Pharmacies, by Region, Through 2028
Table 15 : Global Market for Anti-obesity Drugs, by Region, Through 2028
Table 16 : North American Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 17 : North American Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 18 : European Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 19 : European Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 20 : Asia-Pacific Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 21 : Asia-Pacific Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 22 : Rest of the World Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 23 : Rest of the World Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 24 : ESG Ratings and Metrics
Table 25 : Environmental Performance
Table 26 : Social Performance
Table 27 : Governance Performance
Table 28 : ESG Rankings for Major Anti-obesity Drug Companies, 2023*
Table 29 : Anti-obesity Drugs in Clinical Trials, 2023
Table 30 : Patents on Obesity Management, 2020-2023
Table 31 : Altimmune: Pipeline Products
Table 32 : Altimmune: News, 2023
Table 33 : Boehringer Ingelheim: Pipeline Products
Table 34 : Boehringer Ingelheim: News, 2023
Table 35 : Currax Pharmaceuticals LLC: Products
Table 36 : Currax Pharmaceuticals LLC: News, 2022
Table 37 : Eli Lilly: Pipeline Products
Table 38 : Eli Lilly: News, 2023
Table 39 : ROCHE: Products
Table 40 : GlaxoSmithKline: Products
Table 41 : Novo Nordisk A/S: Products
Table 42 : Novo Nordisk A/S: Pipeline Products
Table 43 : Novo Nordisk A/S: News, 2023
Table 44 : Pfizer: Pipeline Products
Table 45 : Pfizer: News, 2023
Table 46 : Rhythm Pharmaceuticals: Products
Table 47 : Rhythm Pharmaceuticals: Pipeline Products
Table 48 : Rhythm Pharmaceuticals: News, 2023
Table 49 : VIVUS LLC: Products
Table 50 : VIVUS LLC: News, 2023
Summary Table : Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 1 : Definitions of Adult Obesity and Overweight
Table 2 : Number of People, Aged Over 5 Years, and Percentage of the Population With Overweight or Obesity, 2020-2035
Table 3 : Global Obesity Trends for Children and Adolescents, Aged 5 to 19 Years, by Gender, 2020-2035
Table 4 : Global Obesity Trends for Adults, Aged 20 Years and Above, by Gender, 2020-2035
Table 5 : Global Economic Impact of High BMI (BMI ?25kg/m?), 2020-2035
Table 6 : Global Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 7 : Difference between Prescription Drugs and Over-the-Counter Anti-obesity Drugs
Table 8 : Approved Prescription Drugs to Treat Overweight and Obesity
Table 9 : Global Market for Anti-obesity Prescription Drugs, by Region, Through 2028
Table 10 : Global Market for Over-the-Counter Anti-obesity Drugs, by Region, Through 2028
Table 11 : Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 12 : Global Market for Anti-obesity Drugs Sold through Hospital Pharmacies, by Region, Through 2028
Table 13 : Global Market for Anti-obesity Drugs Sold through Retail Pharmacies, by Region, Through 2028
Table 14 : Global Market for Anti-obesity Drugs Sold through Online Pharmacies, by Region, Through 2028
Table 15 : Global Market for Anti-obesity Drugs, by Region, Through 2028
Table 16 : North American Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 17 : North American Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 18 : European Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 19 : European Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 20 : Asia-Pacific Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 21 : Asia-Pacific Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 22 : Rest of the World Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 23 : Rest of the World Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 24 : ESG Ratings and Metrics
Table 25 : Environmental Performance
Table 26 : Social Performance
Table 27 : Governance Performance
Table 28 : ESG Rankings for Major Anti-obesity Drug Companies, 2023*
Table 29 : Anti-obesity Drugs in Clinical Trials, 2023
Table 30 : Patents on Obesity Management, 2020-2023
Table 31 : Altimmune: Pipeline Products
Table 32 : Altimmune: News, 2023
Table 33 : Boehringer Ingelheim: Pipeline Products
Table 34 : Boehringer Ingelheim: News, 2023
Table 35 : Currax Pharmaceuticals LLC: Products
Table 36 : Currax Pharmaceuticals LLC: News, 2022
Table 37 : Eli Lilly: Pipeline Products
Table 38 : Eli Lilly: News, 2023
Table 39 : ROCHE: Products
Table 40 : GlaxoSmithKline: Products
Table 41 : Novo Nordisk A/S: Products
Table 42 : Novo Nordisk A/S: Pipeline Products
Table 43 : Novo Nordisk A/S: News, 2023
Table 44 : Pfizer: Pipeline Products
Table 45 : Pfizer: News, 2023
Table 46 : Rhythm Pharmaceuticals: Products
Table 47 : Rhythm Pharmaceuticals: Pipeline Products
Table 48 : Rhythm Pharmaceuticals: News, 2023
Table 49 : VIVUS LLC: Products
Table 50 : VIVUS LLC: News, 2023
LIST OF FIGURES
Summary Figure : Global Market for Anti-obesity Drugs, by Distribution Channel, 2021–2028
Figure 1 : Global Market for Anti-obesity Drugs: SWOT Analysis
Figure 2 : Global Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 3 : Global Market for Anti-obesity Prescription Drugs, by Region, 2021-2028
Figure 4 : Global Market for Over-the-Counter Anti-obesity Drugs, by Region, 2021-2028
Figure 5 : Global Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 6 : Global Market for Anti-obesity Drugs Sold through Hospital Pharmacies, by Region, 2021-2028
Figure 7 : Global Market for Anti-obesity Drugs Sold through Retail Pharmacies, by Region, 2021-2028
Figure 8 : Global Market for Anti-obesity Drugs Sold through Online Pharmacies, by Region, 2021-2028
Figure 9 : Global Market Shares of Anti-obesity Drugs, by Region, 2023
Figure 10 : North American Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 11 : North American Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 12 : European Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 13 : European Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 14 : Asia-Pacific Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 15 : Asia-Pacific Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 16 : Rest of the World Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 17 : Rest of the World Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Summary Figure : Global Market for Anti-obesity Drugs, by Distribution Channel, 2021–2028
Figure 1 : Global Market for Anti-obesity Drugs: SWOT Analysis
Figure 2 : Global Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 3 : Global Market for Anti-obesity Prescription Drugs, by Region, 2021-2028
Figure 4 : Global Market for Over-the-Counter Anti-obesity Drugs, by Region, 2021-2028
Figure 5 : Global Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 6 : Global Market for Anti-obesity Drugs Sold through Hospital Pharmacies, by Region, 2021-2028
Figure 7 : Global Market for Anti-obesity Drugs Sold through Retail Pharmacies, by Region, 2021-2028
Figure 8 : Global Market for Anti-obesity Drugs Sold through Online Pharmacies, by Region, 2021-2028
Figure 9 : Global Market Shares of Anti-obesity Drugs, by Region, 2023
Figure 10 : North American Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 11 : North American Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 12 : European Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 13 : European Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 14 : Asia-Pacific Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 15 : Asia-Pacific Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 16 : Rest of the World Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 17 : Rest of the World Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
